Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin
International Journal of Urology · 2026-04 · 33 (4)
DOI: 10.1111/iju.70445 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Urology, online erschienen am 27.03.2026. Verfasst von Ahmet Yıldırım Balık und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Duzce University Faculty of Medicine, Duzce, Türkiye. Hauptthemen laut MEDLINE: Antibiotic Prophylaxis, Ciprofloxacin, Gentamicins, Ceftriaxone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To compare the effectiveness and safety of two antibiotic prophylaxis regimens, ciprofloxacin plus gentamicin and ceftriaxone plus cefixime, in preventing infectious complications after transrectal ultrasound‐guided prostate biopsy.
Methods
The study retrospectively reviewed 705 consecutive patients who underwent transrectal ultrasound‐guided prostate biopsy between January 2020 and January 2024. Group 1 ( n = 374) received ciprofloxacin plus gentamicin, and Group 2 ( n = 331) received ceftriaxone plus cefixime. All patients underwent standard rectal preparation with povidone‐iodine, and needle‐tip disinfection with formalin. The primary outcome was the development of post‐biopsy infectious complications, while secondary outcomes included sepsis and infection‐related hospitalization.
Results
The two groups were comparable in terms of age, body mass index, prostate‐specific antigen levels, and comorbidities. The overall rate of post‐biopsy infection was 1.4%, occurring in 1.1% patients in Group 1 and 1.8% patients in Group 2 ( p = 0.61). The incidence of complicated urinary tract infection was 0.3% versus 0.9%, and infection‐related hospitalization occurred in 0.5% versus 0.3% of patients in Group 1 and Group 2, respectively, with no cases of sepsis observed. In univariable analyses, diabetes mellitus, histopathological chronic prostatitis, and pre‐biopsy antibiotic use were not significantly associated with post‐biopsy infection.
Conclusion
The combination of ceftriaxone and cefixime showed a safety profile broadly consistent with the combination of ciprofloxacin and gentamicin for biopsy prophylaxis. Considering increasing fluoroquinolone resistance and growing restrictions, this cephalosporin‐based regimen may be considered a feasible option for transrectal ultrasound‐guided prostate biopsy when implemented together with strict antiseptic measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Duzce University Faculty of Medicine, Duzce, Türkiye.
ORCID-Profile: Ahmet Yıldırım Balık, Emre Ediz, Burak Ayvacık, Arda Taşkın Taşkıran, Ekrem Başaran, Dursun Baba
Zitieren
APA
Balık, A. Y., Ediz, E., Ayvacık, B., Taşkıran, A. T., Başaran, E., & Baba, D. (2026). Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin. International Journal of Urology, 33(4). https://doi.org/10.1111/iju.70445
Vancouver
Balık AY, Ediz E, Ayvacık B, Taşkıran AT, Başaran E, Baba D. Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin. International Journal of Urology. 2026;33(4). doi:10.1111/iju.70445
BibTeX
@article{Balk2026,
author = {Balık, Ahmet Yıldırım and Ediz, Emre and Ayvacık, Burak and Taşkıran, Arda Taşkın and Başaran, Ekrem and Baba, Dursun},
title = {Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin},
journal = {International Journal of Urology},
year = {2026},
volume = {33},
number = {4},
doi = {10.1111/iju.70445}
}
EUVIMED